Sano Chemicals
About this raise: Sano Chemicals, with a valuation of $50.01 million, is raising funds on StartEngine. The company has developed a breakthrough solution for tackling drug-resistant fungal infections. Sano Chemicals’ flagship product, Occidiofungin, has successfully completed the first part of Phase 1 FDA human trials to treat recurrent vulvovaginal candidiasis and will soon bring innovative treatment to the market. The company has been in talks with pharmaceutical companies and might enter into a license and development agreement after the completion of Phase 2 trials. Timothy Hiebert and Dr. Janice L. Miles founded Sano Chemicals in March 2012. The current crowdfunding campaign has a minimum target of $123,999.48 and a maximum target of $4.9 million. The campaign proceeds will be used for research and development, inventory, company employment, working capital, and marketing.
Investment Overview
Committed $69,188 :
Deal Terms
Company & Team
Company
- Year Founded
- 2012
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- Medium
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $743,500
- Grants
- $115,000
- VC Backed?
- No
Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|
04/10/2025 | StartEngine | $50,010,300 | $69,188 | Equity - Common | Active | RegCF |